Home » Topics » Patents, BioWorld Science

Patents, BioWorld Science
RSS

Emory University patents CXCR4 antagonists and their use in cancer

Nov. 24, 2004

Merck claims prostaglandin analogues as EP4 receptor agonists for ocular and bone conditions

Nov. 24, 2004

GSK researchers identify new ROCK inhibitors for use in cardiovascular and other disorders

Nov. 24, 2004

New GLP-2 derivatives and their use in gastrointestinal disorders

Nov. 24, 2004

New angiotensin II receptor agonists covered by Vicore patent

Nov. 24, 2004

Antitumor treatments described in patent literature

Nov. 23, 2004

Dual acting piperidine derivatives claimed by AstraZeneca

Nov. 23, 2004

Merck presents series of sodium channel blockers

Nov. 23, 2004

IRM patents cathepsin D inhibitors for rheumatoid arthritis, osteoarthritis, inflammation, etc.

Nov. 23, 2004

Cannabinoid CB2 receptor modulators described in a patent

Nov. 23, 2004

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 15, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 15, 2026.
SERPINB1 as potential biomarker for spinocerebellar ataxia type 2
BioWorld Science
Researchers from Goethe-Universität and collaborators investigated novel molecular biomarker candidates for spinocerebellar ataxia type 2, a progressive...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...
JPM 2026: Year kicks off with biopharma Q4 revenue and guidance
BioWorld
It was a battle of the companies with drugs for transthyretin-mediated amyloidosis on the first day of the J.P. Morgan 2026 Healthcare Conference with Alnylam...